Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Burns, Jorge S ^a,b   Kristiansen, Malthe ^a   Kristensen, Lars P ^c   Larsen, Kenneth H ^a   Nielsen, Maria O ^c   Christiansen, Helle ^c   Nehlin, Jan ^d   Andersen, Jens S ^c   Kassem, Moustapha ^a,e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Institute of Clinical Research   (Denmark)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD146 ANTIGEN; CD31 ANTIGEN; ENDOGLIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GALECTIN 1; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; TIE 1 RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BC 8 CELL; BD 11 CELL; CARCINOGENESIS; CELL CLONE; CELL DEATH; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DECELLULARIZED MATRIX; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LGALS 1 GENE; MESENCHYMAL STEM CELL; MIGRATION INHIBITION; MITOSIS; MOLECULAR DYNAMICS; MORPHOGENESIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ANIMAL; CELL LINE; CONFOCAL MICROSCOPY; DRUG SCREENING; GENETICS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NONOBESE DIABETIC MOUSE; PATHOLOGY; PROTEOMICS; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANIMALS; BLOTTING, WESTERN; CELL LINE; FEMALE; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960114673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021888     Document Type: Article

References (119)

1. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, et al. (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992.
2. Riggi N, Suva ML, De Vito C, Provero P, Stehle JC, et al. (2010) EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 24: 916-932.
3. DuBois SG, Marina N, Glade-Bender J, (2010) Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data. Cancer 116: 749-757.
4. Bolontrade MF, Zhou RR, Kleinerman ES, (2002) Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo. Clin Cancer Res 8: 3622-3627.
5. van der Schaft DW, Hillen F, Pauwels P, Kirschmann DA, Castermans K, et al. (2005) Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65: 11520-11528.
6. Arroyo AG, Iruela-Arispe ML, (2010) Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 86: 226-235.
7. Hynes RO, (2009) The extracellular matrix: not just pretty fibrils. Science 326: 1216-1219.
8. Hynes RO, (2007) Cell-matrix adhesion in vascular development. J Thromb Haemost 5 (Suppl 1): 32-40.
9. Au P, Tam J, Fukumura D, Jain RK, (2008) Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111: 4551-4558.
10. Corselli M, Chen CW, Crisan M, Lazzari L, Peault B, (2010) Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 30: 1104-1109.
11. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, et al. (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65: 3126-3135.
12. Burns JS, Abdallah BM, Shroder HD, Kassem M, (2008) The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma? Histol Histopathol 23: 1229-1240.
13. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, et al. (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23: 5095-5098.
14. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, et al. (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20: 592-596.
15. Abdallah BM, Haack-Sorensen M, Burns JS, Elsnab B, Jakob F, et al. (2005) Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 326: 527-538.
16. Huang NF, Li S, (2008) Mesenchymal stem cells for vascular regeneration. Regen Med 3: 877-892.
17. Gong Z, Niklason LE, (2008) Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22: 1635-1648.
18. Ingber DE, Folkman J, (1989) Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 109: 317-330.
19. Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, et al. (2004) Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 127: 399-405.
20. Kadri T, Lataillade JJ, Doucet C, Marie A, Ernou I, et al. (2005) Proteomic study of Galectin-1 expression in human mesenchymal stem cells. Stem Cells Dev 14: 204-212.
21. Bauer AL, Jackson TL, Jiang Y, (2009) Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis. PLoS Comput Biol 5: e1000445.
22. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, et al. (2000) Genes expressed in human tumor endothelium. Science 289: 1197-1202.
23. Chen CS, Toda KI, Maruguchi Y, Matsuyoshi N, Horiguchi Y, et al. (1997) Establishment and characterization of a novel in vitro angiogenesis model using a microvascular endothelial cell line, F-2C, cultured in chemically defined medium. In Vitro Cell Dev Biol Anim 33: 796-802.
24. Korff T, Augustin HG, (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 112: 3249-3258.
25. Francis ME, Uriel S, Brey EM, (2008) Endothelial cell-matrix interactions in neovascularization. Tissue Eng Part B Rev 14: 19-32.
26. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, et al. (2007) Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13: 1325-1331.
27. Young RM, Wang SJ, Gordan JD, Ji X, Liebhaber SA, et al. (2008) Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J Biol Chem 283: 16309-16319.
28. Fierro-Monti I, Mohammed S, Matthiesen R, Santoro R, Burns JS, et al. (2006) Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E. J Proteome Res 5: 1367-1378.
29. Magagnin MG, van den Beucken T, Sergeant K, Lambin P, Koritzinsky M, et al. (2008) The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency. Proteomics 8: 1019-1028.
30. Rosova I, Dao M, Capoccia B, Link D, Nolta JA, (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26: 2173-2182.
31. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, et al. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
32. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
33. Zhang J, Fukuhara S, Sako K, Takenouchi T, Kitani H, et al. (2011) Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of {beta}-catenin. J Biol Chem.
34. Chen CL, Chan PC, Wang SH, Pan YR, Chen HC, (2010) Elevated expression of protein kinase C delta induces cell scattering upon serum deprivation. J Cell Sci 123: 2901-2913.
35. Meyer RD, Sacks DB, Rahimi N, (2008) IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One 3: e3848.
36. Carmona G, Gottig S, Orlandi A, Scheele J, Bauerle T, et al. (2009) Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 113: 488-497.
37. Bohman S, Matsumoto T, Suh K, Dimberg A, Jakobsson L, et al. (2005) Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis. J Biol Chem 280: 42397-42404.
38. Virgintino D, Ozerdem U, Girolamo F, Roncali L, Stallcup WB, et al. (2008) Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res 45: 129-131.
39. Nehls V, Denzer K, Drenckhahn D, (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270: 469-474.
40. Davis GE, Senger DR, (2008) Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr Opin Hematol 15: 197-203.
41. DeQuach JA, Mezzano V, Miglani A, Lange S, Keller GM, et al. (2010) Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PLoS One 5: e13039.
42. Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, et al. (2008) Degradation Products of Extracellular Matrix Affect Cell Migration and Proliferation. Tissue Eng Part A.
43. Sorrell JM, Baber MA, Caplan AI, (2008) Human dermal fibroblast subpopulations; differential interactions with vascular endothelial cells in coculture: nonsoluble factors in the extracellular matrix influence interactions. Wound Repair Regen 16: 300-309.
44. Palmieri D, Valli M, Viglio S, Ferrari N, Ledda B, et al. (2010) Osteoblasts extracellular matrix induces vessel like structures through glycosylated collagen I. Exp Cell Res 316: 789-799.
45. Soucy PA, Romer LH, (2009) Endothelial cell adhesion, signaling, and morphogenesis in fibroblast-derived matrix. Matrix Biol 28: 273-283.
46. Klein G, Muller CA, Tillet E, Chu ML, Timpl R, (1995) Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 86: 1740-1748.
47. Ruhl M, Sahin E, Johannsen M, Somasundaram R, Manski D, et al. (1999) Soluble collagen VI drives serum-starved fibroblasts through S phase and prevents apoptosis via down-regulation of Bax. J Biol Chem 274: 34361-34368.
48. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, et al. (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023-2030.
49. Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, et al. (2010) ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One 5: e12093.
50. Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, et al. (2005) Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 166: 1259-1263.
51. Rangel R, Sun Y, Guzman-Rojas L, Ozawa MG, Sun J, et al. (2007) Impaired angiogenesis in aminopeptidase N-null mice. Proc Natl Acad Sci U S A 104: 4588-4593.
52. Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, et al. (2004) MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167: 757-767.
53. van Hinsbergh VW, Engelse MA, Quax PH, (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26: 716-728.
54. del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, et al. (2010) Identification and functional analysis of endothelial tip cell-enriched genes. Blood 116: 4025-4033.
55. Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, et al. (2010) Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One 5.
56. Ghajar CM, Kachgal S, Kniazeva E, Mori H, Costes SV, et al. (2010) Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res 316: 813-825.
57. Valentine A, O'Rourke M, Yakkundi A, Worthington J, Hookham M, et al. (2011) FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism. Clin Cancer Res 17: 1044-1056.
58. Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE, (2008) Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 28: 1703-1713.
59. Semon JA, Nagy LH, Llamas CB, Tucker HA, Lee RH, et al. (2010) Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res 341: 147-158.
60. Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL, (2003) Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 424: 398-405.
61. Kotecki M, Zeiger AS, Van Vliet KJ, Herman IM, (2010) Calpain- and talin-dependent control of microvascular pericyte contractility and cellular stiffness. Microvasc Res 80: 339-348.
62. Jean C, Gravelle P, Fournie JJ, Laurent G, (2011) Influence of stress on extracellular matrix and integrin biology. Oncogene.
63. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, et al. (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27: 3746-3753.
64. Iozzoa RV, Sandersonb RD, (2010) Proteoglycans in Cancer Biology, Tumor Microenvironment and Angiogenesis. J Cell Mol Med.
65. Bissell MJ, Barcellos-Hoff MH, (1987) The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci Suppl 8: 327-343.
66. Arnoys EJ, Wang JL, (2007) Dual localization: proteins in extracellular and intracellular compartments. Acta Histochem 109: 89-110.
67. Nadalutti C, Viiri KM, Kaukinen K, Maki M, Lindfors K, (2011) Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis. Cell Prolif 44: 49-58.
68. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, et al. (2008) Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 3: e2518.
69. Boraldi F, Annovi G, Carraro F, Naldini A, Tiozzo R, et al. (2007) Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochim Biophys Acta 1774: 1402-1413.
70. Camby I, Le Mercier M, Lefranc F, Kiss R, (2006) Galectin-1: a small protein with major functions. Glycobiology 16: 137R-157R.
71. Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V, (1999) Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3: 317-325.
72. Hovanessian AG, Soundaramourty C, El Khoury D, Nondier I, Svab J, et al. (2010) Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One 5: e15787.
73. Le Mercier M, Mathieu V, Haibe-Kains B, Bontempi G, Mijatovic T, et al. (2008) Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol 67: 456-469.
74. Dings RP, Van Laar ES, Loren M, Webber J, Zhang Y, et al. (2010) Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug Chem 21: 20-27.
75. Inagaki Y, Tang W, Zhang L, Du G, Xu W, et al. (2010) Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis. Biosci Trends 4: 56-60.
76. Braden AR, Kafka MT, Cunningham L, Jones H, Vishwanatha JK, (2009) Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol 9: 2856-2865.
77. Ireson CR, Kelland LR, (2006) Discovery and development of anticancer aptamers. Mol Cancer Ther 5: 2957-2962.
78. Loi M, Marchio S, Becherini P, Di Paolo D, Soster M, et al. (2010) Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. J Control Release 145: 66-73.
79. Demidova-Rice TN, Geevarghese A, Herman IM, (2011) Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro. Wound Repair Regen 19: 59-70.
80. Akhtar N, Dickerson EB, Auerbach R, (2002) The sponge/Matrigel angiogenesis assay. Angiogenesis 5: 75-80.
81. Rappsilber J, Ishihama Y, Mann M, (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75: 663-670.
82. Schandorff S, Olsen JV, Bunkenborg J, Blagoev B, Zhang Y, et al. (2007) A mass spectrometry-friendly database for cSNP identification. Nat Methods 4: 465-466.
83. Cardenas Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernandez MM, et al. (2010) Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8. FASEB J.
84. Bornstein P, (2009) Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 3: 189-200.
85. Graven KK, Farber HW, (1998) Endothelial cell hypoxic stress proteins. J Lab Clin Med 132: 456-463.
86. De Luca A, Gallo M, Aldinucci D, Ribatti D, Lamura L, et al. (2010) The role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol.
87. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, et al. (2009) Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 113: 233-243.
88. Kubota Y, Kawa Y, Mizoguchi M, (1996) CDw49b/CD29 integrin complex mediates the differentiation of human endothelial cells into capillary-like structures in vitro. J Dermatol Sci 12: 36-43.
89. Mitchell K, Szekeres C, Milano V, Svenson KB, Nilsen-Hamilton M, et al. (2009) Alpha3beta1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3. J Cell Sci 122: 1778-1787.
90. Cai W, Chen X, (2006) Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med Chem 6: 407-428.
91. Primo L, Seano G, Roca C, Maione F, Gagliardi PA, et al. (2010) Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane. Cancer Res 70: 5759-5769.
92. Abraham S, Kogata N, Fassler R, Adams RH, (2008) Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res 102: 562-570.
93. Leifheit-Nestler M, Conrad G, Heida NM, Limbourg A, Limbourg FP, et al. (2010) Overexpression of integrin beta 5 enhances the paracrine properties of circulating angiogenic cells via Src kinase-mediated activation of STAT3. Arterioscler Thromb Vasc Biol 30: 1398-1406.
94. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
95. Neufeld G, Kessler O, (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8: 632-645.
96. Huang Y, Shi H, Zhou H, Song X, Yuan S, et al. (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107: 3564-3571.
97. Keerl S, Gehmert S, Gehmert S, Song YH, Alt E, (2010) PDGF and bFGF modulate tube formation in adipose tissue-derived stem cells. Ann Plast Surg 64: 487-490.
98. Gaultier A, Salicioni AM, Arandjelovic S, Gonias SL, (2006) Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression. J Biol Chem 281: 7332-7340.
99. Manevich E, Grabovsky V, Feigelson SW, Alon R, (2007) Talin 1 and paxillin facilitate distinct steps in rapid VLA-4-mediated adhesion strengthening to vascular cell adhesion molecule 1. J Biol Chem 282: 25338-25348.
100. Liu WF, Zuo HJ, Chai BL, Peng D, Fei YJ, et al. (2011) Role of tetraspanin CD151-alpha3/alpha6 integrin complex: Implication in angiogenesis CD151-integrin complex in angiogenesis. Int J Biochem Cell Biol 43: 642-650.
101. Leis M, Marschall M, Stamminger T, (2004) Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol 85: 1995-2000.
102. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, et al. (2005) Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280: 20833-20841.
103. Bougatef F, Quemener C, Kellouche S, Naimi B, Podgorniak MP, et al. (2009) EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114: 5547-5556.
104. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, et al. (1996) Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest 75: 55-66.
105. Zanetti M, Braghetta P, Sabatelli P, Mura I, Doliana R, et al. (2004) EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol 24: 638-650.
106. Wang J, Milner R, (2006) Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling. J Neurochem 96: 148-159.
107. Zhang H, Gao X, Weng C, Xu Z, (2008) Interaction between angiogenin and fibulin 1: evidence and implication. Acta Biochim Biophys Sin (Shanghai) 40: 375-380.
108. Korn R, Rohrig S, Schulze-Kremer S, Brinkmann U, (2005) Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genes. Bioinformatics 21: 2766-2772.
109. Lin JL, Wang MJ, Lee D, Liang CC, Lin S, (2008) Hypoxia-inducible factor-1alpha regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells. FEBS Lett 582: 2615-2619.
110. Zhou Z, Wang J, Cao R, Morita H, Soininen R, et al. (2004) Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 64: 4699-4702.
111. Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, et al. (2006) Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J 20: 717-719.
112. Irigoyen M, Anso E, Salvo E, de las Herrerias JD, Martinez-Irujo JJ, et al. (2008) TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci 65: 2244-2255.
113. Myrsky E, Kaukinen K, Syrjanen M, Korponay-Szabo IR, Maki M, et al. (2008) Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin Exp Immunol 152: 111-119.
114. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, et al. (2004) Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18: 754-756.
115. Shiga A, Nozaki H, Yokoseki A, Nihonmatsu M, Kawata H, et al. (2011) Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-{beta}1 via cleavage of proTGF-{beta}1. Hum Mol Genet.
116. Silvestre JS, Thery C, Hamard G, Boddaert J, Aguilar B, et al. (2005) Lactadherin promotes VEGF-dependent neovascularization. Nat Med 11: 499-506.
117. Grieb G, Piatkowski A, Simons D, Hormann N, Dewor M, et al. (2010) Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation. Surgery.
118. Wang J, Wang J, Dai J, Jung Y, Wei CL, et al. (2007) A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 67: 149-159.
119. Cheng CW, Yeh JC, Fan TP, Smith SK, Charnock-Jones DS, (2008) Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophys Res Commun 365: 285-290.